Clinical Trial Update: A Phase 1, Study to Evaluate HTI-2088 Tablet [Phase 1]

View source ↗

Summary

This Phase 1 trial evaluating HTI-2088 tablets in participants with diabetes has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes

Drugs mentioned

• HTI-2088 Tablet

Snippet

Sponsor: Hengrui Therapeutics, Inc. | Conditions: Diabetes | Phase 1 | Status: COMPLETED